Clinical Trials Directory

Trials / Conditions / Nivolumab

Nivolumab

7 registered clinical trials studyying Nivolumab — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingIntratumoral Gemcitabine, Paclitaxel, Carboplatine and Intravenous Nivolumab for Locally Recurrence of Head an
NCT05835804
Centre Hospitalier Universitaire, AmiensPhase 2
SuspendedPhase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab
NCT07011550
M.D. Anderson Cancer CenterPhase 2
Enrolling By InvitationNivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma
NCT06871007
St. Petersburg State Pavlov Medical UniversityPhase 1 / Phase 2
Enrolling By InvitationAutologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After
NCT06931613
St. Petersburg State Pavlov Medical UniversityPhase 2
RecruitingSafety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors a
NCT04572451
Yana NajjarPhase 1
UnknownA Study of Nivolumab +/- Docetaxel in Patients Previously Treated With Advanced or Metastatic NSCLC
NCT04023617
Peking University Cancer Hospital & InstitutePhase 2
CompletedCohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program
NCT02933346
Intergroupe Francophone de Cancerologie Thoracique—